In the last trading session, 1.23 million Aldeyra Therapeutics Inc. (NASDAQ:ALDX) shares changed hands as the company’s beta touched 1.53. With the company’s per share
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) has a beta value of 1.52 and has seen 1.16 million shares traded in the last trading session. The company, currently
During the last session, Aldeyra Therapeutics Inc. (NASDAQ:ALDX)’s traded shares were 1.27 million, with the beta value of the company hitting 1.51. At the end
In the last trading session, 1.34 million shares of the Aldeyra Therapeutics Inc. (NASDAQ:ALDX) were traded, and its beta was 1.59. Most recently the company’s
Aldeyra Therapeutics Inc. (NASDAQ:ALDX)’s traded shares stood at 1.17 million during the last session, with the company’s beta value hitting 1.59. At the close of
In the last trading session, 2.35 million Aldeyra Therapeutics Inc. (NASDAQ:ALDX) shares changed hands as the company’s beta touched 1.59. With the company’s per share
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) has a beta value of 1.65 and has seen 12.93 million shares traded in the last trading session. The company, currently
During the last session, Aldeyra Therapeutics Inc. (NASDAQ:ALDX)’s traded shares were 2.89 million, with the beta value of the company hitting 1.65. At the end
Aldeyra Therapeutics Inc. (NASDAQ:ALDX)’s traded shares stood at 0.48 million during the last session, with the company’s beta value hitting 1.67. At the close of